[Evaluation of the efficacy and the cost-effectiveness of proton pump inhibitor-based dual and triple therapy regimens for H. pylori eradication in peptic ulcer disease].

To evaluate the efficacy and the cost-effectiveness of H. pylori eradication for the treatment of peptic ulcer disease, a randomized controlled trial to compare the efficacy of proton pump inhibitor-based dual and triple regimens was conducted. A decision analysis was also performed to assess H. pylori eradication compared to the conventional maintenance strategy. Two hundred and thirty-four peptic ulcer patients suffering from H. pylori infection were randomly treated with either omeprazole 20 mg bid + amoxicillin 500 mg qid + clarithromycin 400 mg bid (OAC) or with omeprazole 20 mg bid + clarithromycin 400 mg bid (OC) for 14 days. The eradication rate with OAC was 87.6% (92/105) (95% Confidence Interval (CI): 81-94%), which was significantly higher than that with OC (61.9% (60/97) (95% CI: 52-72%)) (p < 0.001, chi 2 test). Both regimens were safe and well tolerated. H. pylori eradication was more effective and less costly than conventional strategy in a long term perspective. OAC was more cost-effective than OC. In conclusion, H. pylori eradication is a cost-effective alternative to conventional treatment. We recommend 2 weeks triple regimen with omeprazole 20 mg bid + amoxicillin 500 mg qid + clarithromycin 400 mg bid (OAC) as a first-line treatment in all patients with peptic ulcers associated with H. pylori infection.
AuthorsY Habu, K Kiyota, H Inokuchi, Y Sugano, K Ko, S Waki
JournalNihon rinsho. Japanese journal of clinical medicine (Nihon Rinsho) Vol. 57 Issue 1 Pg. 135-9 (Jan 1999) ISSN: 0047-1852 [Print] JAPAN
PMID10036950 (Publication Type: Clinical Trial, English Abstract, Journal Article, Randomized Controlled Trial)
Chemical References
  • Anti-Ulcer Agents
  • Proton Pump Inhibitors
  • Amoxicillin
  • Clarithromycin
  • Omeprazole
  • Amoxicillin (administration & dosage)
  • Anti-Ulcer Agents (administration & dosage, economics)
  • Clarithromycin (administration & dosage)
  • Cost-Benefit Analysis
  • Drug Evaluation
  • Drug Therapy, Combination (administration & dosage)
  • Helicobacter Infections (drug therapy, microbiology)
  • Helicobacter pylori (isolation & purification)
  • Humans
  • Omeprazole (administration & dosage)
  • Peptic Ulcer (drug therapy, microbiology)
  • Proton Pump Inhibitors
  • Treatment Outcome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!

Choose Username:
Verify Password: